Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
LIFE SCIENCES RESEARCH INC (LSR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/23/2009 |
8-K
| Quarterly results |
10/21/2009 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
09/08/2009 |
8-K
| Other Events |
08/18/2009 |
8-K
| Other Events |
07/24/2009 |
8-K
| Form 8-K - Current report |
07/09/2009 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
06/05/2009 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
05/21/2009 |
8-K
| Form 8-K -- Current report |
05/04/2009 |
8-K
| Form 8-K -- Current report |
03/12/2009 |
8-K
| Form 8-K -- Current report |
03/04/2009 |
8-K
| Form 8-K -- Current report |
03/04/2009 |
8-K
| Other Events |
03/03/2009 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
05/21/2008 |
8-K
| Form 8-K -- Current report |
03/03/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
02/28/2008 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
08/03/2007 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
05/24/2007 |
8-K
| Other Events |
12/22/2006 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
12/08/2006 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ... |
07/05/2006 |
8-K
| Termination of a Material Definitive Agreement |
06/13/2006 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
05/22/2006 |
8-K
| Other Events |
03/06/2006 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
09/08/2005 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
08/22/2005 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
06/16/2005 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs:
|
"Contract for the Sale and Purchase, between Huntingdon Life Sciences Limited and Alconbury Properties I Limited, relating to the Huntingdon, England facility",
"Contract for the Sale and Purchase, between Huntingdon Life Sciences Limited and Alconbury Properties II Limited, relating to the Eye, England facility",
"Purchase and Sale Agreement, between Huntingdon Life Sciences Inc. and Alconbury Properties III Limited relating to the East Millstone, NJ facility",
"Lease, among Alconbury Properties I Limited, ServicePharm Limited and LSR, relating to the Huntingdon, England facility",
"Lease, dated as of June 14, 2005, among Alconbury Properties II Limited, ServicePharm Limited and LSR, relating to the Eye, England facility",
"Lease Agreement, dated as of June 14, 2005, between Alconbury Properties III Limited and ServicePharm Inc., relating to the East Millstone, New Jersey facility",
"Loan Note Instrument, constituting (pound)5,500,041 ($10,000,000) Variable Rate Secured Loan Stock 2010 of Alconbury Properties I Limited",
"LSR ANNOUNCES FULL REPAYMENT OF BANK DEBT WITH PROCEEDS FROM SALE LEASEBACK AND INTERNAL CASH" |
|
03/07/2005 |
8-K
| Other Events, Financial Statements and Exhibits
Docs:
|
"code 39138. We suggest calling five minutes prior to the scheduled call. Life Sciences Research, Inc. is a global Contract Research Organization providing product development services to the pharmaceutical, agrochemical and biotechnology industries. LSR brings leading technology and capability to support its clients in non-clinical safety testing of new compounds in early stage development and assessment. The purpose of this work is to identify risks to humans, animals or the environment resulting from the use or manufacture of a wide range of chemicals which are essential components of LSR's clients' products. The Company's services are designed to meet the regulatory requirements of governments around the world. LSR operates research facilities in the United States (the Princeton Research Center, New Jersey) and the United Kingdom (Huntingdon and Eye, England). Information on LSR's business, recent press releases, and SEC filings can be obtained through its website at www.lsrinc.net. This announcement contains statements that may be forward-looking as defined by the USA's Private Securities Litigation Reform Act of 1995. These statements are based largely on LSR's expectations and are subject to a number of risks and uncertainties, certain of which are beyond LSR's control, as more fully described in the Company's SEC filings, including its Form 10-K for the fiscal year ended December 31, 2003. - tables to follow -" |
|
12/02/2004 |
8-K
| Other Events |
05/26/2004 |
8-K
| Other events, Financial statements and exhibits |
03/22/2004 |
8-K
| Other events, Financial statements and exhibits |
09/11/2003 |
8-K
| Other events |
02/28/2003 |
8-K
| Changes in registrant's certifying accountant, Financial statements and exhibits |
06/17/2002 |
8-K
| Other events |
|
|
|